New Heart Drug Cuts Teen Disease Symptoms by 97%

A precision medicine breakthrough offers teenagers with a dangerous inherited heart condition their first targeted therapy, dramatically reducing obstruction and potentially healing heart damage.

The drug mavacamten could transform treatment for young patients who previously faced limited options beyond invasive surgery.